Poster Presentations
101 - Transkingdom RNA Interference (tkRNAi): A Novel Delivery Tool for Therapeutic RNA Interference
Jens Harborth, Associate Director RNAi Research, Cequent Pharmaceuticals
102 - Targeting APP with Chemically Modified siRNA (stealthRNAi™) Ameliorates Alzheimer’s Disease Neuropathology in a Transgenic Mouse Model
Christofer Cunning, Product Manager - RNAi Technologies, Invitrogen
103 - Validating microRNA Targeting of Downregulated Breast Cancer Biomarkers
Debra Ann Nickson, Regional Business Manager - Gene Expression Profiling, Invitrogen
104 - RhoB is Regulated by RhoA Through a RhoGDIalpha-Dependent Mechanism
Giang Ho, PhD Student, University of Liege
105 - A Foamy-Virus System Expressing Small Interfering RNA, for Gene Knockdown in Mammalian Cells
Magdalini Papadaki, PhD Student, Biomedical Research Foundation, Academy of Athens
106 - RNAi of p68 RNA Helicase Regulates de Proto-Oncogen c-H-Ras
Montse Bach-Elias, Staff Scientist, CSIC
107 - How to Perform High Throughput siRNA Transfection
Hanno Hermann, Product Manager, CyBio AG
108 - Highly Efficient Delivery of RNA Interference to Peripheral Neurons in vivo Using Herpes Simplex Virus
Marianna Anesti, Senior Scientist, BioVEX Ltd
109 - Influence of microRNA Feed Back Loop in Cocaine-Induced Synaptic Plasticity
Vijay Chandrasekar, Research Scientist, University of Fribourg, Switzerland
110 - Functional Effects of RNAi Mediated Glucocorticoid Receptor Knockdown in the Mouse Brain
Lenneke van Hooijdonk, PhD Student, Leiden/Amsterdam Center for Drug Research/ LUMC
111 - Assessment System for Allele-Specific Gene Silencing by RNA Interference with Mutant and Wild-Type Reporter Alleles
Hirohiko Hohjoh, Section Chief, National Institute of Neuroscience, NCNP
112 - siRNA Overhangs Modifications to Enhance Gene Silencing
Anne-Laure Bolcato-Bellemin, in vivo Research Manager, Polyplus-transfection
113 - Technology Trends in RNAi
Gary Oosta, Chief Science Officer, Oval Ideas, Inc.
114 - Gene Silencing of Transcription Factor Gli2 Inhibits Basal Cell Carcinoma-Like Tumour Growth in vivo
Mark Ji, Staff Scientist, Institute of Medical Microbiology, University of Basel
115 - microRNA Expression During Development of Oral Tissues
Anne Marthe Jevnaker, PhD Student, University of Oslo
116 - Synthesis of Modified siRNA to Inhibit Gene Expression in vitro
Sandra Milena Ocampo, PhD Student, University of Barcelona, Faculty of Medicine
117 - Targeting a Single Nucleotide Polymorphism in vivo with RNA Interference
Olaf Mook, Postdoctoral Fellow, Academic Medical Centre
118 - siRNA Delivery to Hard-to-Transfect Cells Using the N-TER Nanoparticle Transfection System
Lyle Ralston, Senior Scientist, Sigma-Aldrich
119 - Quantification of siRNA by a Novel Competitive-qPCR Method
Wei-Li Liu, Student, Oxford University
120 - Exploring Mutant p53 Gain of Function in vivo Through Conditional RNA Interference
Gianluca Bossi, PhD Student, Regina Elena Cancer Institute
121 - The Anti-Apoptotic Factor Che-1/AATF Links Transcriptional Regulation, Cell Cycle Control, and DNA Damage Response
Maurizio Fanciulli, Staff Scientist, Regina Elena Cancer Institute
122 - The Inhibition of Cell Proliferation and Migration by siRNA for N-Cadherin in Human Melanoma Cell Lines
Dorota Ciolczyk-Wierzbicka, Chair of Medical Biochemistry, CMUJ, Poland
123 - In vivo Application of RNA-Interference in the Central Nervous System: The Role of Doublecortin-Like in Neurogenesis and in Retrograde Transport of the Glucocorticoid Receptor
Erno Vreugdenhil, Associate Professor, University of Leiden
124 - Inhibition of Myofibroblast Differentiation by Silencing Transforming Growth Factor Beta Receptor
Yu-Qian Chau, PhD Student, University of Queensland, Australia
125 - Suppression of Rat Neuronal P2X7 Receptor Expression Using Viral Vector-Mediated shRNA Delivery
Chiara Cazzin, Associate Scientist, GlaxoSmithKline
126 - Sensitive and Specific Detection of microRNAs and Other Noncoding RNAs
Ina Scheuerpflug, Senior Marketing Manager GSi, QIAGEN
128 - microRNA-210 Modulates Endothelial Cell Response to Hypoxia and Ephrin-A3 levels
Pasquale Fasanaro, PhD Student, Istituto Dermopatico dell'Immacolata, IRCCS
129 - Effects of Gene Silencing by RNA Interference in Acute and Persistent Measles Virus Infections
Claire Fabian, PhD Student, Institute of Virology
130 - Cellaxess HT - An Electroporation-Based Delivery Technology Suitable for Genome-wide RNAi Screening
Johan Pihl, Project Manager R&D, Cellectricon AB
131 - Human Stable Clones Silenced for More than 20 DNA Repair Genes Designed to Untangle the Relationships Between DNA Repair Pathways
Nadia Normand, Bioassay Manager, tebu-bio
132 - Identification and Validation of Downstream Targets of TFII-I Proteins
Nyam-Osor Chimge, Research Scientist, University of Louisville
133 - LNA Based microRNA Expression Profiling
Nina Stahlberg, Senior Scientist, Exiqon
134 - The Ultimate Proof of Specificity: Rescue Your RNAi Phenotype Using BACs
Sibylle Blumenthal, Senior Scientist, Gene Bridges GmbH
135 - Single ES Cell Profiling Reveals Unique microRNA Expression Signatures and Heterogeneities
Susan Magdaleno, Manager, Scientists – RNAi, Ambion, An Applied Biosystems Business
136 - A Pipeline for Designing Custom TaqMan® Assays for Small RNA Genes
Michel Cannieux, Marketing Applications, Ambion, Applied Biosystems
137 - Advanced Data Mining Software for Applied Biosystems Real-time-PCR Data Analysis
Astrid Ferlinz, Senior European Application Specialist, Applied Biosystems
138 - A High Complexity Assay to Profile MicroRNA Expression
Stephanie Brooking, Senior Business Development Specialist RNA Europe, Applied Biosystems
139 - A Novel Therapeutic Approach for Treating Glaucoma by RNAi
Angela Sesto, Senior Researcher, Sylentis
140 - Computational Analysis of Small RNA Cloning Data
Philipp Berninger, PhD Student, Biozentrum, University of Basel
141 - Determinants of miRNA and siRNA Targeting Specificity in Mammals
Jean Hausser, PhD Student, Biozentrum, University of Basel
142 - Role of microRNAs in Ginsenoside-Rg1-Induced Angiogenesis
Lai Sheung Chan, Student, Hong Kong Baptist University
143 - The Drosophila RNA Methyltransferase, DmHen1, Modifies Germline piRNAs and Single-Stranded siRNAs in RISC
Michael Horwich, MD/PhD Student, University of Massachusetts Medical School
144 - The Silencing of Multidrug Resistance Protein 5 by Sirna Complexes
Melina Malinen, PhD Student, University of Helsinki
145 - Porcine Adenovirus as a Viral Vector for Short Hairpin RNAs
David Cummins, PhD Student, CSIRO and The University of Melbourne
146 - Identification of New Potential Therapeutic Targets Associated to Cell Proliferation and Chemo Resistance in Human Glioblastoma Cells U373
Sophie Chappuis, CEO, TRANSAT
147 - Altered Retinal microRNA Expression Profile in Mouse Model of Retinitis Pigmentosa
Carol Loscher, PhD Student, Trinity College Dublin
148 - Silencing of Kv3.4 Gene Expression Using Small-Interfering RNA
Tatiana Tkatch, Research Associate Professor, Northwestern University
149 - An Inducible Genome-Wide Human Lentiviral shRNAmir Library for Mammalian RNAi
Gwen Fewell, Product Manager for RNAi, Open Biosystems
150 - A Validated Library of Lentiviral shRNAmir Targeting Cancer Genes
Karin Schmitt, Senior Director, Scientific Development, Open Biosystems
151 - siRNA-Mediated Multitarget Inhibition of Antiapoptotic BCL2, BCLXL and XIAP in Bladder Cancer Cells
Doreen Kunze, PhD Student, Technical University of Dresden
152 - Highly Efficient High-Throughput Transfection of Hard-to-Transfect Cell Types for RNAi Based Applications
Markus Zumbansen, Senior Scientist, Amaxa GmbH
153 - Characterization of PROMAXX Small Interfering RNA and Antisense Oligonucleotide Microspheres for Pulmonary Delivery
Kimberly Gillis, Senior Research Scientist, Baxter Healthcare Corporation
154 - In vivo Strategies for Cell-Surface Receptor Knockdown Using Nuclease-Resistant Small Interfering RNA: Plasma Pharmacokinetics, Stability and Cellular Uptake
Paul White, Senior Lecturer, Monash University
155 - Effects of Nuclease Stability on the in vitro and in vivo Cellular Uptake, Biodistribution and Pharmacokinetics of siRNA
Nga Cao, Student, Monash University
156 - Functional Validation of a Novel Cancer Target by Lentiviral shRNA Delivery
Alexandra Iché, Head Bioinformatics, VECTALYS
157 - shRNA Transgenic Rat Model for Inducible Diabetes Mellitus Type II
Katarina Kotnik, PhD Student, Max-Delbrück-Centre for Molecular Medicine (MDC) Berlin Buch
158 - Genome Wide shRNA Library Screen to Identify Genes Modulating BCR/ABL Inhibitor Sensitivity in the Chronic Myelogenous Leukemia Cell Line K562
Matthias Truss, Group Leader, Charité
159 - Complete in vivo Reversal of the Multidrug Resistance (MDR) Phenotype by Jet-Injection of Anti-MDR1 Short Hairpin RNA-Encoding Plasmid DNA
Hermann Lage, Investigator, Charité
160 - Enhancer of Zeste Homolog 2 (EZH2) – A New Target of the HPV18 E7 Oncogene?
Daniela Holland, PhD Student, German Cancer Research Centre
161 - The Use of siRNA as a Therapeutic Approach for Retinitis Pigmentosa Caused by Splicing Mutations
Imma Hernan, Pre-Doctoral Student, Hospital de Terrassa
162 - Suppression of Hepatocellular Carcinoma Progression by Systemic Adenovirus-Mediated Transfer of shRNA Against Plk1
Albrecht Piiper, Group Leader, University of Saarland
163 - microRNAs Involvement in Human Breast and Ovarian Cancer
Marilena Iorio, PhD Student, National Institute of Cancer, Milan, Italy
164 - miRNA Induction in Hypoxia
Carme Camps, Postdoctoral Fellow, The Wellcome Trust Centre for Human Genetics (University of Oxford)
165 - Regulation of miRNA Target mRNA Levels by Differentially Expressed miRNAs in the Hypothalamus of an Anorexia Mouse Model
Josep Mercader, Scientist, Centre for Genomic Regulation, Barcelona Biomedical Research Park
166 - Characterisation of micro-RNA Expression Profiles of Mouse Bone Marrow Cells
Salla Suomi, PhD Student, University of Turku
167 - miRNAs Expression Profile Associated to Neuronal Oxidative Stress Suggest a Role for miRNAs in Neurodegenerative Processes
Elena Miñones-Moyano, PhD Student, Centre Regulació Genomica (CRG)
168 - Development of an Automated siRNA Screening of Host Macrophages Genes Involved in Mycobacterium Tuberculosis Infection
Jean-Philippe Carralot, Post-Doctoral Fellow, Pasteur Institute Korea
169 - The Geniom® Platform Provides an Ideal Tool for the High-Throughput Analysis of miRNAs
Julia Schliwka, Scientific Marketing Manager, febit biotech
170 - Cytokine Regulate miRNAs Linked to Muscle Differentiation
Christian Thirion, Group Leader, Ludwig-Maximilians-University Munich
171 - Inhibition of the Growth Suppressor Gene Necdin Results in Increased Proliferation of Primary Murine Hepatocytes
Urda Rüdrich, PhD Student, MHH - Twincore
172 - SIROCCO: Silencing RNAs - Organisers and Coordinators of Complexity in Eukaryotic Organisms
Aileen Hogan, Project Manager SIROCCO, The Sainsbury Laboratory
Copyrights
For any submitted abstract, we assume that:
- All co-authors are responsible and aware of the content.
- Select Biosciences is authorised to use in the proceedings the abstracts of the selected presentations (oral or posters).
- Select Biosciences is authorised to use the abstract summaries and biographies of the selected speakers on this website and in the proceedings.